They found that when STING was activated, two transcription factors called TFEB and TFE3 were shuttled to the nucleus of ...
This dual action—targeting both protein aggregation and mitochondrial dysfunction—positions TFE3 as a promising therapeutic candidate for Parkinson's disease. By bolstering the brain's natural ...
Early work revealed that TFEB is highly effective in ameliorating tau/NFT pathology and rescuing cognitive impairment and neurodegeneration. TFEB targets only the aberrant tau species and this ...
Their findings revealed that upon STING activation, the transcription factors TFEB and TFE3 were translocated to the nucleus, ...